Patients With Rheumatoid Arthritis (RA) Treated With Rituximab in Kuopio University Hospital (KuoRituxi1)

K

Kuopio University Hospital

Status

Completed

Conditions

Rheumatoid Arthritis

Treatments

Drug: rituximab, observational study amon patients with active RA
Drug: rituximab

Study type

Observational

Funder types

Other

Identifiers

NCT00854321
KuoRituxi1

Details and patient eligibility

About

One centre follow-up study on safety and efficacy of treatment with rituximab among patients with RA during 4 year period. Basic data is collected for the national register of biologicals.

Full description

Data is collected on regular visits in the outpatient department. In collection national register forms have been used.

Enrollment

49 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • active RA without response to earlier treatment

Exclusion criteria

  • contraindications to rituximab

Trial design

49 participants in 1 patient group

patients with active RA
Description:
drug, follow-up
Treatment:
Drug: rituximab
Drug: rituximab, observational study amon patients with active RA

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems